Ansa Biotechnologies, Inc.
Ansa Biotechnologies, Inc., headquartered in the United States, is a pioneering force in the biotechnology industry, specialising in advanced DNA synthesis and genomic technologies. Founded in 2018, the company has rapidly established itself as a leader in synthetic biology, focusing on innovative solutions for research and therapeutic applications. Ansa Biotechnologies offers unique, high-fidelity DNA synthesis services that cater to a diverse range of sectors, including pharmaceuticals, agriculture, and environmental science. Their proprietary technology enables rapid and cost-effective production of custom DNA sequences, setting them apart in a competitive market. With a commitment to quality and precision, Ansa Biotechnologies has achieved significant milestones, positioning itself as a trusted partner for researchers and companies seeking cutting-edge biotechnological solutions.
DitchCarbon Score
How does Ansa Biotechnologies, Inc.'s carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.
Industry Average
Mean score of companies in the Health Services industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.
Industry Benchmark
Ansa Biotechnologies, Inc.'s score of 18 is lower than 67% of the industry. This can give you a sense of how well the company is doing compared to its peers.
Let us know if this data was useful to you
Ansa Biotechnologies, Inc.'s reported carbon emissions
Ansa Biotechnologies, Inc., headquartered in the US, currently does not have any reported carbon emissions data, as indicated by the absence of specific figures in kg CO2e. Additionally, the company has not established any documented reduction targets or climate pledges. As there are no emissions or commitments available, it is unclear how Ansa Biotechnologies is addressing climate change or carbon management within its operations. The lack of data may suggest that the company is in the early stages of developing its sustainability strategy or reporting framework. In the context of the biotechnology industry, many companies are increasingly focusing on reducing their carbon footprints and setting science-based targets to align with global climate goals. Ansa Biotechnologies may need to consider adopting similar initiatives to enhance its environmental responsibility and transparency.
Industry emissions intensity
Location emissions intensity
Reduction initiatives & disclosure networks
Companies disclose and commit to reducing emissions to show they are serious about reducing emissions impact over time. They can also help a company track its progress over time.
Ansa Biotechnologies, Inc. is not participating in any of the initiatives that we track. This may change over time as the company engages with new initiatives or updates its commitments. DitchCarbon will update this information as it becomes available.
